| Valeri Lynn Roth, DO | |
|
2395 Garden Way, Hermitage, PA 16148-5209 | |
| (724) 342-5890 | |
| (724) 342-3874 |
| Full Name | Valeri Lynn Roth |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 32 Years |
| Location | 2395 Garden Way, Hermitage, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457334997 | NPI | - | NPPES |
| 1389672 | Other | PA | BS |
| 0019085300008 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | OS008320L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sharon Regional Health System | Sharon, PA | Hospital |
| Upmc Horizon | Greenville, PA | Hospital |
| Entity Name | Valeri L Roth D O P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710316583 PECOS PAC ID: 5496985483 Enrollment ID: O20140314000057 |
News Archive
"On Monday, N2Care, a company formed by a Methodist minister in Salem, Va., showed off its first MedCottage, a 12-by-24-foot prototype filled with biometric technology that would allow a family and health-care providers to monitor the condition of an aging or disabled relative. … [T]he Virginia General Assembly this year passed legislation, HB1307, that supersedes local zoning laws and allows families to install such a dwelling on their property with a doctor's order."
Today's headlines feature reports that UnitedHealthcare plans to honor some health law provisions regardless of what the Supreme Court decides.
For patients with Clostridium difficile (C. difficile), a persistent and potentially deadly bacterial illness, severe diarrhea, abdominal pain, nausea and vomiting are an everyday event. This particularly virulent infection is prone to recurrence, even after multiple courses of expensive antibiotics, and treatment options are limited for patients who continually relapse or develop antibiotic resistance.
Algeta Retains Option for Co-promotion and Profit Sharing in USA - Potential deal value of $800 million (EUR560m*) plus tiered double digit royalties - Algeta to receive $61 million (EUR42.5m) cash upfront, followed by development and sales milestones - Algeta retains option for co-promotion and profit-sharing in USA - Algeta and Bayer will jointly develop Alpharadin, with Bayer contributing a substantial majority of the costs of future development
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valeri Lynn Roth, DO 2395 Garden Way, Hermitage, PA 16148-5209 Ph: (724) 342-5890 | Valeri Lynn Roth, DO 2395 Garden Way, Hermitage, PA 16148-5209 Ph: (724) 342-5890 |
News Archive
"On Monday, N2Care, a company formed by a Methodist minister in Salem, Va., showed off its first MedCottage, a 12-by-24-foot prototype filled with biometric technology that would allow a family and health-care providers to monitor the condition of an aging or disabled relative. … [T]he Virginia General Assembly this year passed legislation, HB1307, that supersedes local zoning laws and allows families to install such a dwelling on their property with a doctor's order."
Today's headlines feature reports that UnitedHealthcare plans to honor some health law provisions regardless of what the Supreme Court decides.
For patients with Clostridium difficile (C. difficile), a persistent and potentially deadly bacterial illness, severe diarrhea, abdominal pain, nausea and vomiting are an everyday event. This particularly virulent infection is prone to recurrence, even after multiple courses of expensive antibiotics, and treatment options are limited for patients who continually relapse or develop antibiotic resistance.
Algeta Retains Option for Co-promotion and Profit Sharing in USA - Potential deal value of $800 million (EUR560m*) plus tiered double digit royalties - Algeta to receive $61 million (EUR42.5m) cash upfront, followed by development and sales milestones - Algeta retains option for co-promotion and profit-sharing in USA - Algeta and Bayer will jointly develop Alpharadin, with Bayer contributing a substantial majority of the costs of future development
› Verified 7 days ago
Dr. David Eugene Wood, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1623 Dutch Ln, Hermitage, PA 16148 Phone: 724-962-3210 Fax: 724-962-9034 |